PTGX - Protagonist Therapeutics, Inc
94.83
3.530 3.722%
Share volume: 745,540
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$91.30
3.53
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-07-2024 | 02-21-2025 | 05-06-2025 | 08-06-2025 | 11-06-2025 | 02-25-2026 | |
| Cash flow financing | 7.199 M | 2.572 M | 12.051 M | 4.031 M | 11.443 M | 2.925 M | 5.659 M | 2.837 M | |
| Other financing cash flows | -600.000 K | 0.000 | 0.000 | 0.000 | -479.000 K | 0.000 | 0.000 | 0.000 | |
| Cash flow | -14.159 M | 183.075 M | -224.522 M | -33.872 M | 42.404 M | 28.955 M | -54.833 M | 14.677 M | |
| Net income | 207.340 M | -30.616 M | -33.210 M | 131.674 M | -11.655 M | -34.771 M | -39.339 M | -44.384 M | |
| Depreciation | 236.000 K | 241.000 K | 231.000 K | 118.000 K | 239.000 K | 304.000 K | 361.000 K | 376.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 6.071 M | -88.119 M | -208.710 M | -8.725 M | -94.402 M | 54.810 M | -58.555 M | 48.815 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 242.000 K | 28.000 K | 775.000 K | 310.000 K | 545.000 K | 813.000 K | 88.000 K | 144.000 K | |
| Cash Change | -14.159 M | 183.075 M | -224.522 M | -33.872 M | 42.404 M | 28.955 M | -54.833 M | 14.677 M |